PharmaManufacturing: Taking Vaccines to the World
BioPham International: March 2009 - Tanks for the Memories
BioPharm International: Jan 2009
An Alternative to the Scale-Up and Distribution of Pandemic Influenza Vaccine. With baculovirus-based production in disposable equipment, vaccine can be available 10 to 12 weeks after an outbreak.
An influenza pandemic is a global health risk and many solutions are being developed to attempt to address this serious threat. Vaccination is thought to be a preferred solution, although access to a timely and sufficient supply of vaccine against a new emerging pandemic strain is inadequate in every country around the world. A new approach makes it possible to provide vaccine within 10 to 12 weeks of identification of a new viral strain, with an exact match to the wild-type influenza strain, by using disposables-based manufacturing facilities that can be built more quickly and cheaply than traditional vaccines plants.